Porcine Circovirus remains in the spotlight of European researchers
Ingelheim, Germany, 16 February
2011 – The fourth edition of the European PCV2
Research Award sponsored by Boehringer Ingelheim saw a record
number of applications showing the continued interest in Porcine
Circovirus Type 2 (PCV2) research: 13 researchers from ten
different countries submitted proposals.
Clinical disease associated with PCV2 infection is not a major
issue nowadays as pigs can be protected very effectively by
vaccination, and piglet vaccination has become routine use
worldwide. Still, PCV2 remains to be a potential threat for global
swine production and more research is needed to better understand
the immunological aspects, the pathogenesis and epidemiology of
this devastating disease, as well as the interaction of PCV2 with
other potential pathogens.
It is Boehringer Ingelheim’s intention to continuously support independent applied research in this field. A maximum of three prizes, each 25,000 euros, are granted to European researchers every year. The 2010 awards were recently presented to the award winners by Prof. Maurice Pensaert, former head of the Laboratory of Virology of the Ghent University in Belgium and chairman of the independent review board selecting the awarded projects, and Dr Joachim Hasenmaier, Head of Animal Health at Boehringer Ingelheim. The ceremony took place at the global headquarters of Boehringer Ingelheim in Ingelheim, Germany.